Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
B Cell Maturation Antigen（BMCA）-Targeted CAR-T for Refractory/Relapsed Multiple Myeloma
ClinicalTrials.gov study NCT03931421. IPD Sharing: YES. Countries: 1. Publications: 0.
JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia
ClinicalTrials.gov study NCT06940960. IPD Sharing: NO. Countries: 1. Publications: 0.
Window Trial to Evaluate Molecular Response to PI3K Inhibition With Copanlisib in r/r Adult B-cell ALL
ClinicalTrials.gov study NCT04803123. IPD Sharing: NO. Countries: 1. Publications: 0.
Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study
ClinicalTrials.gov study NCT07236203. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research
ClinicalTrials.gov study NCT06277011. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.
ClinicalTrials.gov study NCT01848132. IPD Sharing: NO. Countries: 1. Publications: 0.
Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma
ClinicalTrials.gov study NCT06609304. IPD Sharing: NO. Countries: 1. Publications: 0.
Multi-CAR-T Cells Targeting B Cell Lymphomas
ClinicalTrials.gov study NCT04429438. IPD Sharing: NO. Countries: 1. Publications: 0.
Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete Remission
ClinicalTrials.gov study NCT00458523. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Rituximab Plus Zanubrutinib and Lenalidomide for Relapsed and Refractory Diffuse Large B Cell Lymphoma, a Multicenter, Open and Prospective Clinical Trial
ClinicalTrials.gov study NCT05392257. IPD Sharing: YES. Countries: 1. Publications: 0.
CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies
ClinicalTrials.gov study NCT05105867. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT04433182. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies
ClinicalTrials.gov study NCT03366324. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of TG-1801 in Subjects With B-Cell Lymphoma
ClinicalTrials.gov study NCT03804996. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MIL62 in Treatment of CD20 Positive B-cell Lymphomas
ClinicalTrials.gov study NCT04103905. IPD Sharing: NO. Countries: 1. Publications: 0.
Lenalidomide in Combination With R-GemOx in First-line Treatment of Elderly Diffuse Large B Cell Lymphoma
ClinicalTrials.gov study NCT04432402. IPD Sharing: YES. Countries: 1. Publications: 0.
An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders
ClinicalTrials.gov study NCT06721598. IPD Sharing: NO. Countries: 1. Publications: 0.
Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT07159906. IPD Sharing: NO. Countries: 1. Publications: 0.
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
ClinicalTrials.gov study NCT06689917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Early Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CT
ClinicalTrials.gov study NCT00256490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.